Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-16

FDA Approved: BUDESONIDE INHALATION SUSPENSION — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for Budesonide Inhalation Suspension, a generic inhaled corticosteroid, for maintenance treatment of asthma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation Suspension (budesonide)

Snippet

ORIG AP for BUDESONIDE INHALATION SUSPENSION (BUDESONIDE)